Publication: 524

Publication: 524

A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)

URL

URL

Google Scholar

Citation:: J Thorac Oncol vol 4 (9, suppl 1) S816, abstract P2.212

Meeting Instance:: IASLC (WCLC) 2009
Year:: 2009
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 198

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:: CA03927, CA114558-02, CA11789, CA31946, CA31983, CA32291, CA33601, CA35113, CA35279, CA41287, CA45418, CA45808, CA47642, CA77298, CA77406, CA77597, CA77658, CA86726, U10 CA031946-28, U10 CA033601

Corr. Author:
Authors:: Antonius A. Miller Herbert Pang Lydia Hodgson Nithya Ramnath Gregory A. Otterson Michael J. Kelley Robert A. Kratzke Everett E. Vokes

Networks:

Study: CALGB-30602
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Phase II, Dasatinib, Small cell lung cancer